DETERMINATION OF ANTIPARKINSONISM DRUG ENTACAPONE
Spectrophotometric procedures are presented for the determination of the antiparkinsonism drug entacapone. The first method based on the formation of a coloured complex of entacapone with ferric chloride in ethanolic solutions. The coloured product is quantified spectrophotometrically at 665nm. The...
Guardado en:
Autores principales: | GADALLAH MOHAMED,NASHWAH, SULTAN MOHAMED,MOHAMED |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Chilena de Química
2010
|
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072010000100020 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Entacapone reduces cortical activation in Parkinson's disease with wearing-off: a f-MRI study.
por: Nicola Tambasco, et al.
Publicado: (2014) -
Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease
por: Herrán E, et al.
Publicado: (2014) -
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo®)
por: Paolo Solla, et al.
Publicado: (2010) -
Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
por: David J Brooks
Publicado: (2008) -
Hybrid inner-outer algorithm for solving real-world mechanical optimization problems
por: Omnia Osman Fadel Abouhabaga, et al.
Publicado: (2021)